Reducing Eating Disorder Risk Factors
The purpose of this study is to determine whether a web-based program is effective in reducing the incidence of eating disorders in college women who are at high risk for developing an eating disorder.
Behavioral: Web-based intervention to reduce eating disorder risk factors
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Interventions to Reduce Eating Disorder Risk Factors|
- Onset of an eating disorder [ Time Frame: 2 years ] [ Designated as safety issue: No ]The main outcome is the onset of an eating disorder, as defined by DSM-IV
- Change in eating disorder behaviors [ Time Frame: 2 years ] [ Designated as safety issue: No ]Eating disorder behaviors as measured by the Eating Disorder Examination. We will also measure attitudes related to eating disorder onset risk
|Study Start Date:||February 2001|
|Primary Completion Date:||April 2012 (Final data collection date for primary outcome measure)|
Female college students who use unhealthy weight control methods and have body image concerns may be at risk for developing an eating disorder. Developing and evaluating interventions to reduce eating disorders in high-risk populations is of great public health importance.
Participants are randomly assigned to either join a web-based risk-reduction program or receive no intervention. The 9-week risk-reduction program focuses on reducing body image and weight/shape concerns, identifying the risks of eating disorders, and increasing healthy weight regulation practices. The program includes weekly readings, writing assignments, and participation in a moderated electronic discussion group. Changes in body mass index (BMI) and the occurrence of major stressors and psychiatric events are assessed to determine their impact on the incidence of eating disorders. One-year incidence of eating disorders is determined by a diagnostic interview, and follow up may continue for up to 2.5 years.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00050570
|United States, California|
|Stanford University, Dept. of Psychiatry and Behavioral Sciences|
|Stanford, California, United States, 94305|